Perineural injection of etanercept as a treatment for postamputation pain

Keyphrases

• After Injection 33%
• Amputee 33%
• Drug Class 33%
• Effective Treatment 33%
• Etanercept 100%
• Functional Capacity 33%
• Inflammatory Cytokines 33%
• Local Administration 66%
• Neuropathic Pain 33%
• No Adverse Effect 33%
• Pain at Rest 33%
• Pain Behavior 33%
• Pain Conditions 66%
• Perineural 66%
• Perineural Injection 100%
• Phantom Limb Pain 66%
• Postamputation Pain 100%
• Psychologic 33%
• Reduced Dose 33%
• Residual Limb Pain 66%
• Safe Treatment 33%
• Soldiers 66%
• Systemic Administration 33%
• Systemic Treatment 33%
• Tumor Necrosis Factor-α 66%
• Tumour Necrosis Factor Inhibitor (TNFi) 33%
• Well-being 33%

Medicine and Dentistry

• Adverse Event 33%
• Amputee 33%
• Assertiveness 33%
• Clinical Study 33%
• Etanercept 100%
• Functional Status 33%
• Inflammatory Cytokine 33%
• Limb Pain 66%
• Neuropathic Pain 33%
• Perineural Drug Administration 100%
• Phantom Pain 66%
• Systemic Administration 33%
• Systemic Therapy 33%
• TNF Inhibitor 33%
• Tumor Necrosis Factor 66%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 33%
• Clinical Study 66%
• Cytokine 33%
• Etanercept 100%
• Functional Status 33%
• Limb Pain 66%
• Neuropathic Pain 33%
• Phantom Pain 66%
• Preclinical Study 33%
• Systemic Administration 33%
• Systemic Treatment 33%
• Tumor Necrosis Factor 66%
• Tumor Necrosis Factor Inhibitor 33%